DUBLIN, Calif., Oct. 30 /PRNewswire-FirstCall/ -- SuperGen Inc. today announced that James S. Manuso, Ph.D., President and Chief Executive Officer, will present a corporate overview and highlight SuperGen's recent developments at the Rodman & Renshaw 8th Annual Healthcare Conference, at 12:25 p.m. EST, on Nov. 6, 2006, at the New York Palace Hotel in New York City.
A live Webcast of Dr. Manuso's presentation will be available on the Investor Relations section of the Company's website at http://www.supergen.com. The Webcast will be archived for 90 days.
About SuperGen
Based in Dublin, Calif., SuperGen is a pharmaceutical company dedicated to the discovery, acquisition, rapid development and commercialization of therapies for solid tumors and hematological malignancies. SuperGen is developing a number of therapeutic anticancer products focused on inhibitors of aurora-A, tyrosine kinase and DNA methyltransferase. For more information about SuperGen, please visit http://www.supergen.com.
Contacts: SuperGen Noonan Russo Timothy L. Enns Sharon Weinstein, S.V.P., (212) 845-4271 (Investors) Corporate Communications sharon.weinstein@eurorscg.com & Business Development Tracey Milani, (925) 560-0100 x111 (858) 546-4811 (Media) tenns@supergen.comtracey.milani@eurorscg.com
SuperGen Inc.CONTACT: Timothy L. Enns, S.V.P. SuperGen Corporate Communications &Business Development, +1-925-560-0100 ext. 111, tenns@supergen.com; SharonWeinstein, Investors, +1-212-845-4271, sharon.weinstein@eurorscg.com, orTracey Milani, Media, +1-858-546-4811, tracey.milani@eurorscg.com, both ofNoonan Russo
Web site: http://www.supergen.com/
